H. Lode
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 60
-
- Antibiotic Use and Resistance 19
- Pharmacology top 0.1%
- Antibiotics Pharmacokinetics and Efficacy 113
-
- Nosocomial Infections in ICU 26
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 17
-
- Pneumonia and Respiratory Infections 102
- Pneumocystis jirovecii pneumonia detection and treatment 22
-
- Drug Transport and Resistance Mechanisms 15
- Journals
- Antimicrobial Agents and Chemotherapy (25 papers)European Respiratory Journal (14 papers)Journal of Antimicrobial Chemotherapy (14 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
H. Lode
260 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Medicine 1.2k
- Applied Microbiology and Biotechnology 370
- Pharmacology 2.5k
- Critical Care and Intensive Care Medicine 723
- Infectious Diseases 2.3k
Countries citing papers authored by H. Lode
This map shows the geographic impact of H. Lode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lode more than expected).
Fields of papers citing papers by H. Lode
This network shows the impact of papers produced by H. Lode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lode. The network helps show where H. Lode may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Lode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 5 | |
| 2 | 2010 | 162 | |
| 3 | 2009 | 72 | |
| 4 | 2008 | 0 | |
| 5 | 2008 | 74 | |
| 6 | 2008 | 0 | |
| 7 | 2005 | 41 | |
| 8 | 2005 | 10 | |
| 9 | 2004 | 10 | |
| 10 | 2004 | 2 | |
| 11 | 2004 | 35 | |
| 12 | 2001 | 6 | |
| 13 | 2000 | 1 | |
| 14 | Prophylaxe und Therapie von bronchialen Infektionen: Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie | 1997 | 3 |
| 15 | 1997 | 28 | |
| 16 | 1996 | 12 | |
| 17 | 1995 | 42 | |
| 18 | Cefotetan : a long-acting antibiotic | 1985 | 7 |
| 19 | 1982 | 4 | |
| 20 | Changes in pulmonary function of young people as a result of cigarette smoking over many years. | 1971 | 2 |
About H. Lode
H. Lode is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 277 papers that have together received 8.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (113 papers), Pneumonia and Respiratory Infections (102 papers), Antibiotic Resistance in Bacteria (60 papers), Nosocomial Infections in ICU (26 papers), Pneumocystis jirovecii pneumonia detection and treatment (22 papers), Antibiotic Use and Resistance (19 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and Drug Transport and Resistance Mechanisms (15 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Applied Microbiology and Biotechnology (370 citations) and Pharmacology (2.5k citations). H. Lode has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ralf Stahlmann, P. Koeppe, T. Schaberg, K. Börner, A de Roux, G. Höffken, H. Mauch, Mathias W. Pletz, David W. Denning and Klaus Borner. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, European Respiratory Journal, Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.